Analysts view the syphilis immunoassay diagnostics market as a dynamic and growing sector, primarily driven by the rising prevalence of syphilis cases globally and increased awareness surrounding sexually transmitted infections (STIs).
Public health initiatives promoting regular screening are contributing to heightened demand for effective diagnostic solutions. Technological advancements, particularly in point-of-care testing, are enhancing the speed and accuracy of diagnoses, making them more accessible
Key players in the market, including Abbott Laboratories and Roche Diagnostics, are investing in product innovation, focusing on multiplex assays that can detect multiple STIs simultaneously. However, the market faces challenges such as stringent regulatory requirements and limited access in low-income regions.
Looking ahead, there is significant growth potential in emerging markets and through the integration of digital health technologies, which could improve testing accessibility and patient management. Overall, the syphilis immunoassay diagnostics market is positioned for expansion, provided stakeholders can effectively navigate existing challenges
The rise in launches of syphilis immunoassay diagnostics products is expected to propel the growth of the global syphilis immunoassay diagnostics market over the forecast period. As manufacturers continue to introduce new and innovative diagnostic tests, the market is expected to experience a significant surge in demand. These new product launches offer improved sensitivity, specificity, and ease of use, making them more appealing to healthcare professionals and patients alike.
Furthermore, the increasing availability of point-of-care tests and rapid diagnostic tests is expanding the market's reach, particularly in resource-limited settings and high-risk population. With a wider range of products available, the market is expected to witness increased adoption, driving growth and revenue expansion.
For instance, in February 2023, Mylab Discovery Solutions, an Indian diagnostic company, announced that it had strengthened its portfolio of rapid tests for sexually transmitted diseases (STDs), including a groundbreaking Syphilis Antibody test.
This novel test detects antibodies (IgG, IgA, IgM) to Treponema Pallidum (TP), providing a reliable aid in the diagnosis of Syphilis. The test's user-friendly design, room temperature storage capabilities, and point-of-care deployment make it an ideal solution for resource-limited settings.
Moreover, in 2023, Simple HealthKit launched an at-home testing kit for syphilis, empowering individuals to take control of their health from the comfort of their own homes. This convenient and user-friendly kit allows users to self-collect samples and receive accurate results, revolutionizing the way syphilis diagnosis is conducted.
| Attribute | Detail |
|---|---|
| Syphilis Immunoassay Diagnostics Drivers |
|
The rising prevalence of syphilis is expected to propel the growth of global syphilis immunoassay diagnostics market over the forecast period. As the number of reported cases continues to rise, the demand for reliable and accurate diagnostic solutions is increasing exponentially.
According to data published by the World Health Organization (WHO) in 2023, new syphilis cases among adults aged 15-49 years increased by 30% between 2020 and 2022 in North America. According to the same source, more than 3,700 congenital syphilis cases were reported in 2022, reflecting an alarming increase by 937% in the past decade in the U.S.
Besides, according to data published by the European Centre for Disease Prevention and Control (ECDC) in 2024, 35,391 confirmed syphilis cases were reported in 29 EU/EEA Member States In 2022, with a crude notification rate of 8.5 cases per 100 000 population, representing a 34% increase in the crude notification rate as compared to 2021, and a 41% increase in comparison with 2018.
Thus, with more people seeking testing and diagnosis, the market for syphilis immunoassay diagnostics is expected to experience significant growth, driven by the increasing need for rapid and accurate diagnosis in sexually transmitted disease (STD) clinics and prenatal care settings in high risk population.
Fund raise for the commercialization of syphilis immunoassay diagnostics products by market players is expected to propel the growth of the global syphilis immunoassay diagnostics market over the forecast period.
This influx of funding will enable market players to effectively commercialize their products, making them more widely available to healthcare providers and patients worldwide. As a result, the market is expected to witness a significant increase in product adoption, driven by the growing demand for accurate and reliable syphilis testing.
For instance, In July 2024, NowDx, a developer of over the counter and point-of-care diagnostic test, had secured a US$ 22.5 Mn funding round to bring its groundbreaking over-the-counter (OTC) syphilis test to market. This innovative test is designed for at-home use, providing individuals with a convenient, affordable, and accurate way to diagnose syphilis from the comfort of their own homes.
With this funding, NowDx is poised to revolutionize the syphilis diagnostic market, eliminating the need for clinic visits and empowering individuals to take control of their health.
The company plans to use the funding to support the commercialization of the test, enabling widespread availability and accessibility, and is expected to capture a significant share of the growing OTC testing market, driving growth and revenue expansion.
The kits and reagents segment is expected to propel the growth of the global syphilis immunoassay diagnostics market due to the increasing demand for rapid and accurate diagnosis of syphilis. These kits and reagents enable healthcare professionals to quickly and reliably diagnose syphilis, and advancements in technology have led to the development of more sensitive and specific syphilis immunoassays.
The growing incidence of syphilis, particularly among high-risk population, is also driving the demand for diagnostic tests, including kits and reagents. Furthermore, the availability of point-of-care (POC) tests and rapid diagnostic tests (RDTs) has made syphilis diagnosis more accessible and affordable, with kits and reagents being a critical component of these tests.
As a result, the kits and reagents segment is expected to experience significant growth, driven by the increasing adoption of syphilis immunoassays in clinical settings, regulatory approvals, and recommendations from authorities such as the U.S. FDA and the WHO.
The dominance of point-of-care (POC) settings in syphilis immunoassay diagnostics is largely driven by the need for rapid and accessible testing in various healthcare environments.
POC tests such as Immunochromatographic Assays (ICAs) allow healthcare providers to deliver immediate results, facilitating timely diagnosis and treatment, especially in community health clinics and remote areas where laboratory infrastructure may be lacking. This immediacy is crucial for controlling syphilis transmission, particularly in high-risk populations.
Moreover, increasing funding for syphilis Point-of-care testing (POCT) by organizations is also expected to propel the growth of Point-of-care testing (POCT) segment over the forecast period
For instance, in September 2022, Chembio Diagnostics, Inc. (a leading point-of-care diagnostics company focused on infectious diseases) announced that it was awarded a US $3.2 Mn contract from the Centers for Disease Control and Prevention (CDC) for the development and clinical validation of a rapid point-of-care (POC) diagnostic test for syphilis. Chembio will undertake to develop a syphilis test and confirm assay based on its Dual Path Platform (DPP) technology and proprietary DPP Micro Reader II.
The assay will be intended to simultaneously and separately detect treponemal and nontreponemal IgM and IgG antibodies. The test should require only 10 µl of fingerstick blood, serum, or plasma and produce results in under 20 minutes.
Additionally, the growing trend of patient self-testing is expected to exhibit the highest compound annual growth rate (CAGR) due to increasing consumer demand for convenient and private testing options. As awareness of sexually transmitted infections rises, individuals are seeking ways to manage their health proactively.
Self-testing empowers patients by providing them with the tools to test for syphilis in the privacy of their homes, thus removing barriers to accessing care and enhancing overall public health outcomes. Together, these trends reflect a shift toward more accessible and user-centered healthcare solutions in the management of syphilis.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
North America’s syphilis immunoassay diagnostics market is expected to experience a significant growth, driven by increasing government initiatives to combat syphilis, which will expand their market presence and increase adoption rates in the region.
For instance, A University of Alabama at Birmingham (UAB)-led consortium had been awarded more than US$ 13 Mn in funding from the Centers for Disease Control and Prevention (CDC) to combat the growing syphilis epidemic in the United States. This significant investment will support efforts to reduce the spread of syphilis, particularly among reproductive-age women, and mitigate the risk of congenital syphilis.
More than US$ 7.7 Mn of the funding will be allocated toward providing reproductive-age women with access to innovative rapid syphilis testing. This initiative aims to reduce the potential for congenital syphilis, which is on the rise across the United States.
Rapid syphilis testing is a critical component of syphilis immunoassay diagnostics, enabling healthcare providers to quickly and accurately diagnose syphilis and provide timely treatment.
The leading players covered in the syphilis immunoassay diagnostics market include Abbott, Becton, Dickinson, and Company (BD), bioMérieux SA, Bio-Rad Laboratories, Inc , Chembio Diagnostics, Inc., Danaher Corporation, DiaSorin S.p.A., Roche Diagnostics (F. Hoffmann-La Roche AG), Fujirebio , QuidelOrtho Corporation, Shenzhen New Industries Biomedical Engineering Co., Ltd., Siemens Healthineers AG, Sekisui Chemical Co Ltd, Thermo Fisher Scientific, Inc., and Trinity Biotech
Each of these players have been have been profiled in the syphilis immunoassay diagnostics market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
| Attribute | Detail |
|---|---|
| Size in 2023 | US$ 548.5 Mn |
| Forecast Value in 2034 | More than US$ 978.5 Mn |
| CAGR | 5.5% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Mn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
The global syphilis immunoassay diagnostics market was valued at US$ 548.5 Mn in 2023.
The global syphilis immunoassay diagnostics market business is projected to cross US$ 978.5 Mn by the end of 2034.
Rising prevalence of hypertension, increasing launches of syphilis immunoassay diagnostics products, and fund raise regarding commercialization of syphilis immunoassay diagnostics products by market players.
The CAGR is anticipated to be 5.5% from 2024 to 2034.
North America is expected to account for the largest share from 2024 to 2034.
Abbott, Becton, Dickinson, and Company (BD), bioMérieux SA, Bio-Rad Laboratories, Inc , Chembio Diagnostics, Inc., Danaher Corporation, DiaSorin S.p.A., Roche Diagnostics (F. Hoffmann-La Roche AG), Fujirebio , QuidelOrtho Corporation, Shenzhen New Industries Biomedical Engineering Co., Ltd., Siemens Healthineers AG, Sekisui Chemical Co Ltd, Thermo Fisher Scientific, Inc., and Trinity Biotech.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Syphilis Immunoassay Diagnostics Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecasts, 2020-2034
4.4.1. Market Revenue Projections (US$ Mn)
4.4.2. Market Volume/Unit Shipments Projections
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Key Industry Events
5.2. Distributors Landscape
5.3. PORTER’s Five Forces Analysis
5.4. End-user Preference
5.5. Epidemiology of Syphilis by Region/Countries
5.6. Government Initiatives by Region/Countries
5.7. Healthcare Expenditure by Region/Country (Health spending Total, US dollars/capita, 2022)
5.8. PESTEL Analysis
5.9. Impact of near patient testing and POC on syphilis market dynamics
5.10. Brand and Pricing Analysis
5.11. Regulatory Scenario by Region/ Country
5.12. Supply Chain Analysis
5.13. Technological Advancements
6. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecasts, By Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Product, 2020-2034
6.3.1. Analyzer
6.3.2. Kits & Reagents
6.4. Market Attractiveness By Product
7. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecasts, By Technology
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Technology, 2020-2034
7.3.1. Chemiluminescence Assay (CLIA)
7.3.2. Enzyme Linked Immunosorbent Assay (ELISA
7.3.3. Immunochromatographic Assay /Lateral Flow Assay
7.3.4. Treponema pallidum latex agglutination (TPLA)
7.3.5. Non-treponemal Flocculation Assay
7.4. Market Attractiveness By Technology
8. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecasts, By Test Type
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Test Type, 2020-2034
8.3.1. Treponemal Tests
8.3.2. Non-Treponemal Tests
8.4. Market Attractiveness By Test Type
9. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecasts, By Location of Testing
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast By Location of Testing, 2020-2034
9.3.1. Point-of-care testing (POCT)
9.3.2. Patient Self-Tests (PST)
9.3.3. Clinical Settings
9.4. Market Attractiveness By Location of Testing
10. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecasts, By End-user
10.1. Introduction & Definition
10.2. Key Findings / Developments
10.3. Market Value Forecast By End-user, 2020-2034
10.3.1. Hospitals and Clinics
10.3.2. Diagnostics Laboratories
10.3.3. Home Care
10.3.4. Public Health Laboratory
10.3.5. Others
10.4. Market Attractiveness By End-user
11. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecasts, By Region
11.1. Key Findings
11.2. Market Value Forecast By Region
11.2.1. North America
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Latin America
11.2.5. Middle East & Africa
11.3. Market Attractiveness By Country/Region
12. North America Syphilis Immunoassay Diagnostics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Product, 2020-2034
12.2.1. Analyzer
12.2.2. Kits & Reagents
12.3. Market Value Forecast By Technology, 2020-2034
12.3.1. Chemiluminescence Assay (CLIA)
12.3.2. Enzyme Linked Immunosorbent Assay (ELISA
12.3.3. Immunochromatographic Assay /Lateral Flow Assay
12.3.4. Treponema pallidum latex agglutination (TPLA)
12.3.5. Non-treponemal Flocculation Assay
12.4. Market Value Forecast By Test Type, 2020-2034
12.4.1. Treponemal Tests
12.4.2. Non-Treponemal Tests
12.5. Market Value Forecast By Location of Testing, 2020-2034
12.5.1. Point-of-care testing (POCT)
12.5.2. Patient Self-Tests (PST)
12.5.3. Clinical Settings
12.6. Market Value Forecast By End-user, 2020-2034
12.6.1. Hospitals and Clinics
12.6.2. Diagnostics Laboratories
12.6.3. Home Care
12.6.4. Public Health Laboratory
12.6.5. Others
12.7. Market Value Forecast By Country, 2020-2034
12.7.1. U.S.
12.7.2. Canada
12.8. Market Attractiveness Analysis
12.8.1. By Product
12.8.2. By Technology
12.8.3. By Test Type
12.8.4. By Location of Testing
12.8.5. By End-user
12.8.6. By Country
13. Europe Syphilis Immunoassay Diagnostics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Product, 2020-2034
13.2.1. Analyzer
13.2.2. Kits & Reagents
13.3. Market Value Forecast By Technology, 2020-2034
13.3.1. Chemiluminescence Assay (CLIA)
13.3.2. Enzyme Linked Immunosorbent Assay (ELISA
13.3.3. Immunochromatographic Assay /Lateral Flow Assay
13.3.4. Treponema pallidum latex agglutination (TPLA)
13.3.5. Non-treponemal Flocculation Assay
13.4. Market Value Forecast By Test Type, 2020-2034
13.4.1. Treponemal Tests
13.4.2. Non-Treponemal Tests
13.5. Market Value Forecast By Location of Testing, 2020-2034
13.5.1. Point-of-care testing (POCT)
13.5.2. Patient Self-Tests (PST)
13.5.3. Clinical Settings
13.6. Market Value Forecast By End-user, 2020-2034
13.6.1. Hospitals and Clinics
13.6.2. Diagnostics Laboratories
13.6.3. Home Care
13.6.4. Public Health Laboratory
13.6.5. Others
13.7. Market Value Forecast By Country, 2020-2034
13.7.1. Germany
13.7.2. U.K.
13.7.3. France
13.7.4. Italy
13.7.5. Spain
13.7.6. Rest of Europe
13.8. Market Attractiveness Analysis
13.8.1. By Product
13.8.2. By Technology
13.8.3. By Test Type
13.8.4. By Location of Testing
13.8.5. By End-user
13.8.6. By Country
14. Asia Pacific Syphilis Immunoassay Diagnostics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Product, 2020-2034
14.2.1. Analyzer
14.2.2. Kits & Reagents
14.3. Market Value Forecast By Technology, 2020-2034
14.3.1. Chemiluminescence Assay (CLIA)
14.3.2. Enzyme Linked Immunosorbent Assay (ELISA
14.3.3. Immunochromatographic Assay /Lateral Flow Assay
14.3.4. Treponema pallidum latex agglutination (TPLA)
14.3.5. Non-treponemal Flocculation Assay
14.4. Market Value Forecast By Test Type, 2020-2034
14.4.1. Treponemal Tests
14.4.2. Non-Treponemal Tests
14.5. Market Value Forecast By Location of Testing, 2020-2034
14.5.1. Point-of-care testing (POCT)
14.5.2. Patient Self-Tests (PST)
14.5.3. Clinical Settings
14.6. Market Value Forecast By End-user, 2020-2034
14.6.1. Hospitals and Clinics
14.6.2. Diagnostics Laboratories
14.6.3. Home Care
14.6.4. Public Health Laboratory
14.6.5. Others
14.7. Market Value Forecast By Country, 2020-2034
14.7.1. China
14.7.2. Japan
14.7.3. India
14.7.4. Australia & New Zealand
14.7.5. Rest of Asia Pacific
14.8. Market Attractiveness Analysis
14.8.1. By Product
14.8.2. By Technology
14.8.3. By Test Type
14.8.4. By Location of Testing
14.8.5. By End-user
14.8.6. By Country
15. Latin America Syphilis Immunoassay Diagnostics Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast By Product, 2020-2034
15.2.1. Analyzer
15.2.2. Kits & Reagents
15.3. Market Value Forecast By Technology, 2020-2034
15.3.1. Chemiluminescence Assay (CLIA)
15.3.2. Enzyme Linked Immunosorbent Assay (ELISA
15.3.3. Immunochromatographic Assay /Lateral Flow Assay
15.3.4. Treponema pallidum latex agglutination (TPLA)
15.3.5. Non-treponemal Flocculation Assay
15.4. Market Value Forecast By Test Type, 2020-2034
15.4.1. Treponemal Tests
15.4.2. Non-Treponemal Tests
15.5. Market Value Forecast By Location of Testing, 2020-2034
15.5.1. Point-of-care testing (POCT)
15.5.2. Patient Self-Tests (PST)
15.5.3. Clinical Settings
15.6. Market Value Forecast By End-user, 2020-2034
15.6.1. Hospitals and Clinics
15.6.2. Diagnostics Laboratories
15.6.3. Home Care
15.6.4. Public Health Laboratory
15.6.5. Others
15.7. Market Value Forecast By Country, 2020-2034
15.7.1. Brazil
15.7.2. Mexico
15.7.3. Rest of Latin America
15.8. Market Attractiveness Analysis
15.8.1. By Product
15.8.2. By Technology
15.8.3. By Test Type
15.8.4. By Location of Testing
15.8.5. By End-user
15.8.6. By Country
16. Middle East & Africa Syphilis Immunoassay Diagnostics Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast By Product, 2020-2034
16.2.1. Analyzer
16.2.2. Kits & Reagents
16.3. Market Value Forecast By Technology, 2020-2034
16.3.1. Chemiluminescence Assay (CLIA)
16.3.2. Enzyme Linked Immunosorbent Assay (ELISA
16.3.3. Immunochromatographic Assay /Lateral Flow Assay
16.3.4. Treponema pallidum latex agglutination (TPLA)
16.3.5. Non-treponemal Flocculation Assay
16.4. Market Value Forecast By Test Type, 2020-2034
16.4.1. Treponemal Tests
16.4.2. Non-Treponemal Tests
16.5. Market Value Forecast By Location of Testing, 2020-2034
16.5.1. Point-of-care testing (POCT)
16.5.2. Patient Self-Tests (PST)
16.5.3. Clinical Settings
16.6. Market Value Forecast By End-user, 2020-2034
16.6.1. Hospitals and Clinics
16.6.2. Diagnostics Laboratories
16.6.3. Home Care
16.6.4. Public Health Laboratory
16.6.5. Others
16.7. Market Value Forecast By Country, 2020-2034
16.7.1. GCC Countries
16.7.2. South Africa
16.7.3. Rest of Middle East & Africa
16.8. Market Attractiveness Analysis
16.8.1. By Product
16.8.2. By Technology
16.8.3. By Test Type
16.8.4. By Location of Testing
16.8.5. By End-user
16.8.6. By Country
17. Competition Landscape
17.1. Market Player - Competition Matrix (By Tier and Size of companies)
17.2. Market Share Analysis, by Company (2023)
17.3. Company Profiles
17.3.1. Abbott
17.3.1.1. Company Overview
17.3.1.2. Financial Overview
17.3.1.3. Product Portfolio
17.3.1.4. Business Strategies
17.3.1.5. Recent Developments
17.3.2. Becton, Dickinson, and Company (BD)
17.3.2.1. Company Overview
17.3.2.2. Financial Overview
17.3.2.3. Product Portfolio
17.3.2.4. Business Strategies
17.3.2.5. Recent Developments
17.3.3. bioMérieux SA
17.3.3.1. Company Overview
17.3.3.2. Financial Overview
17.3.3.3. Product Portfolio
17.3.3.4. Business Strategies
17.3.3.5. Recent Developments
17.3.4. Bio-Rad Laboratories, Inc
17.3.4.1. Company Overview
17.3.4.2. Financial Overview
17.3.4.3. Product Portfolio
17.3.4.4. Business Strategies
17.3.4.5. Recent Developments
17.3.5. Chembio Diagnostics, Inc.
17.3.5.1. Company Overview
17.3.5.2. Financial Overview
17.3.5.3. Product Portfolio
17.3.5.4. Business Strategies
17.3.5.5. Recent Developments
17.3.6. Danaher Corporation
17.3.6.1. Company Overview
17.3.6.2. Financial Overview
17.3.6.3. Product Portfolio
17.3.6.4. Business Strategies
17.3.6.5. Recent Developments
17.3.7. DiaSorin S.p.A.
17.3.7.1. Company Overview
17.3.7.2. Financial Overview
17.3.7.3. Product Portfolio
17.3.7.4. Business Strategies
17.3.7.5. Recent Developments
17.3.8. Roche Diagnostics (F. Hoffmann-La Roche AG)
17.3.8.1. Company Overview
17.3.8.2. Financial Overview
17.3.8.3. Product Portfolio
17.3.8.4. Business Strategies
17.3.8.5. Recent Developments
17.3.9. Fujirebio
17.3.9.1. Company Overview
17.3.9.2. Financial Overview
17.3.9.3. Product Portfolio
17.3.9.4. Business Strategies
17.3.9.5. Recent Developments
17.3.10. QuidelOrtho Corporation
17.3.10.1. Company Overview
17.3.10.2. Financial Overview
17.3.10.3. Product Portfolio
17.3.10.4. Business Strategies
17.3.10.5. Recent Developments
17.3.11. Shenzhen New Industries Biomedical Engineering Co., Ltd.
17.3.11.1. Company Overview
17.3.11.2. Financial Overview
17.3.11.3. Product Portfolio
17.3.11.4. Business Strategies
17.3.11.5. Recent Developments
17.3.12. Siemens Healthineers AG
17.3.12.1. Company Overview
17.3.12.2. Financial Overview
17.3.12.3. Product Portfolio
17.3.12.4. Business Strategies
17.3.12.5. Recent Developments
17.3.13. Sekisui Chemical Co Ltd
17.3.13.1. Company Overview
17.3.13.2. Financial Overview
17.3.13.3. Product Portfolio
17.3.13.4. Business Strategies
17.3.13.5. Recent Developments
17.3.14. Thermo Fisher Scientific, Inc.
17.3.14.1. Company Overview
17.3.14.2. Financial Overview
17.3.14.3. Product Portfolio
17.3.14.4. Business Strategies
17.3.14.5. Recent Developments
17.3.15. Trinity Biotech
17.3.15.1. Company Overview
17.3.15.2. Financial Overview
17.3.15.3. Product Portfolio
17.3.15.4. Business Strategies
17.3.15.5. Recent Developments
List of Tables
Table 01: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, By Product, 2020-2034
Table 02: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, By Technology, 2020-2034
Table 03: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, By Test Type, 2020-2034
Table 04: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, By Location of Testing, 2020-2034
Table 05: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, By End-user , 2020-2034
Table 06: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Region, 2020-2034
Table 07: North America - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country, 2020-2034
Table 08: North America - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, By Product, 2020-2034
Table 09: North America - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2020-2034
Table 10: North America - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, By Test Type, 2020-2034
Table 11: North America - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Location of Testing, 2020-2034
Table 12: North America - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 13: Europe - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Europe - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, By Product, 2020-2034
Table 15: Europe - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2020-2034
Table 16: Europe - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, By Test Type, 2020-2034
Table 17: Europe - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Location of Testing, 2020-2034
Table 18: Europe - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 19: Asia Pacific Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 20: Asia Pacific - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, By Product, 2020-2034
Table 21: Asia Pacific - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2020-2034
Table 22: Asia Pacific - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, By Test Type, 2020-2034
Table 23: Asia Pacific - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Location of Testing, 2020-2034
Table 24: Asia Pacific - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 25: Latin America - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 26: Latin America - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, By Product, 2020-2034
Table 27: Middle East & Africa- Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 28: Latin America - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2020-2034
Table 29: Latin America - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, By Test Type, 2020-2034
Table 20: Latin America - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Location of Testing, 2020-2034
Table 31: Latin America - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 32: Middle East & Africa - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 33: Middle East & Africa - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, By Product, 2020-2034
Table 34: Middle East & Africa - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2020-2034
Table 35: Middle East & Africa - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, By Test Type, 2020-2034
Table 36: Middle East & Africa- Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Location of Testing, 2020-2034
List of Figures
Figure 01: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast, 2020-2034
Figure 02: Global Syphilis Immunoassay Diagnostics Market Value Share, By Product, 2023
Figure 03: Global Syphilis Immunoassay Diagnostics Market Value Share, by Technology, 2023
Figure 04: Global Syphilis Immunoassay Diagnostics Market Value Share, By Test Type, 2023
Figure 05: Global Syphilis Immunoassay Diagnostics Market Value Share, By Location of Testing, 2023
Figure 06: Global Syphilis Immunoassay Diagnostics Market Value Share, by End-user, 2023
Figure 07: Global Syphilis Immunoassay Diagnostics Market Value Share, By Region, 2023
Figure 08: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Share Analysis, By Product, 2023 and 2034
Figure 09: Global Syphilis Immunoassay Diagnostics Market Share Analysis, By Product, 2023
Figure 10: Global Syphilis Immunoassay Diagnostics Market Share Analysis, By Product, 2034
Figure 11: Global Syphilis Immunoassay Diagnostics Market Attractiveness Analysis, By Product, 2024-2034
Figure 12: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn), by Analyzer, 2020-2034
Figure 13: Global Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Analyzer, 2023 and 2034
Figure 14: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn), by Kits & Reagents, 2020-2034
Figure 15: Global Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Finger-Based Devices, 2023 and 2034
Figure 16: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Share Analysis, By Technology, 2023 and 2034
Figure 17: Global Syphilis Immunoassay Diagnostics Market Share Analysis, By Technology, 2023
Figure 18: Global Syphilis Immunoassay Diagnostics Market Share Analysis, By Technology, 2034
Figure 19: Global Syphilis Immunoassay Diagnostics Market Attractiveness Analysis, By Technology, 2024-2034
Figure 20: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn), by Chemiluminescence Assay (CLIA), 2020-2034
Figure 21: Global Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Chemiluminescence Assay (CLIA), 2023 and 2034
Figure 22: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn), by Enzyme Linked Immunosorbent Assay (ELISA), 2020-2034
Figure 23: Global Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Enzyme Linked Immunosorbent Assay (ELISA), 2023 and 2034
Figure 24: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn), by Immunochromatographic Assay /Lateral Flow Assay, 2020-2034
Figure 25: Global Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Immunochromatographic Assay /Lateral Flow Assay, 2023 and 2034
Figure 26: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn), by Treponema pallidum latex agglutination (TPLA), 2020-2034
Figure 27: Global Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Treponema pallidum latex agglutination (TPLA), 2023 and 2034
Figure 28: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn), by Non-treponemal Flocculation Assay, 2020-2034
Figure 29: Global Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Non-treponemal Flocculation Assay, 2023 and 2034
Figure 30: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Share Analysis, By Test Type, 2023 and 2034
Figure 31: Global Syphilis Immunoassay Diagnostics Market Share Analysis, By Test Type, 2023
Figure 32: Global Syphilis Immunoassay Diagnostics Market Share Analysis, By Test Type, 2034
Figure 33: Global Syphilis Immunoassay Diagnostics Market Attractiveness Analysis, By Test Type, 2024-2034
Figure 34: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn), by Treponemal Tests, 2020-2034
Figure 35: Global Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Treponemal Tests, 2023 and 2034
Figure 36: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn), by Non-Treponemal Tests, 2020-2034
Figure 37: Global Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Non-Treponemal Tests, 2023 and 2034
Figure 38: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Share Analysis, By Location of Testing, 2023 and 2034
Figure 39: Global Syphilis Immunoassay Diagnostics Market Share Analysis, By Location of Testing, 2023
Figure 40: Global Syphilis Immunoassay Diagnostics Market Share Analysis, By Location of Testing, 2034
Figure 41: Global Syphilis Immunoassay Diagnostics Market Attractiveness Analysis, By Location of Testing, 2024-2034
Figure 42: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn), by Point-of-care testing (POCT), 2020-2034
Figure 43: Global Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Point-of-care testing (POCT), 2023 and 2034
Figure 44: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn), by Patient Self-Tests (PST), 2020-2034
Figure 45: Global Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Patient Self-Tests (PST), 2023 and 2034
Figure 46: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn), by Clinical Settings, 2020-2034
Figure 47: Global Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Clinical Settings, 2023 and 2034
Figure 48: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Share Analysis, By End-user, 2023 and 2034
Figure 49: Global Syphilis Immunoassay Diagnostics Market Share Analysis, By End-user, 2023
Figure 50: Global Syphilis Immunoassay Diagnostics Market Share Analysis, By End-user, 2034
Figure 51: Global Syphilis Immunoassay Diagnostics Market Attractiveness Analysis, By End-user , 2024-2034
Figure 52: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn), by Hospitals and Clinics, 2020-2034
Figure 53: Global Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Hospitals and Clinics, 2023 and 2034
Figure 54: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn), by Diagnostics Laboratories, 2020-2034
Figure 55: Global Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Diagnostics Laboratories, 2023 and 2034
Figure 56: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn), by Home Care, 2020-2034
Figure 57: Global Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Home Care, 2023 and 2034
Figure 58: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn), by Public Health Laboratory, 2020-2034
Figure 59: Global Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Public Health Laboratory, 2023 and 2034
Figure 60: Global Syphilis Immunoassay Diagnostics Market Value (US$ Mn), by Others, 2020-2034
Figure 61: Global Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Others, 2023 and 2034
Figure 62: Global Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Region, 2023 and 2034
Figure 63: Global Syphilis Immunoassay Diagnostics Market Share Analysis, by Region, 2023
Figure 64: Global Syphilis Immunoassay Diagnostics Market Share Analysis, by Region, 2034
Figure 65: Global Syphilis Immunoassay Diagnostics Market Attractiveness Analysis, by Region, 2023-2034
Figure 66: North America - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 67: North America - Syphilis Immunoassay Diagnostics Market Value Share Analysis, by Country, 2023 and 2034
Figure 68: North America - Syphilis Immunoassay Diagnostics Market Attractiveness Analysis, by Country, 2024-2034
Figure 69: North America - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Share Analysis, By Product, 2023 and 2034
Figure 70: North America - Syphilis Immunoassay Diagnostics Market Attractiveness Analysis, By Product, 2024-2034
Figure 71: North America - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Share Analysis, by Technology, 2023 and 2034
Figure 72: North America - Syphilis Immunoassay Diagnostics Market Attractiveness Analysis, by Technology, 2024-2034
Figure 73: North America - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Share Analysis, By Test Type, 2023 and 2034
Figure 74: North America - Syphilis Immunoassay Diagnostics Market Attractiveness Analysis, By Test Type, 2024-2034
Figure 75: North America - Syphilis Immunoassay Diagnostics Market Value (US$ Mn) Share Analysis, by Location of Testing, 2023 and 2034
Figure 76: North America - Syphilis Immunoassay Diagnostics Market Attractiveness Analysis, by Location of Testing, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Syphilis Immunoassay Diagnostics Market
